Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists ID drug dosage for fungal disease
Aspergillosis is a respiratory fungal disease commonly seen in African penguins under managed care.
Treatment previously caused adverse effects in penguins
 
Liverpool researchers have found the most effective drug dosage to help penguins fight off a common disease.

Aspergillosis is a respiratory fungal disease commonly seen in African penguins under managed care. The anti-fungal medication itraconazole, which was previously used to treat the disease, failed due to drug resistance.

Another anti-fungal called voriconazole has been used recently, but the dosing was based on other avian medications and penguins suffered adverse effects as a result.

Researchers from the University of Liverpool wanted to identify the most effective dose of the drug. Led by Dr Katharine Stott, the team analysed the concentration of voriconazole in plasma taken from African penguins, in order to determine the effectiveness of multiple single and daily oral doses.

This data was used to construct a mathematical model to simulate alternative dosing strategies to find one that replicated the drug exposure that is effective in humans, whilst avoiding toxicity.

The findings, which were published in BioOne, show that 5mg/kg of voriconazole once a day is a safe and effective dosing strategy for African penguins with invasive aspergillosis.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
Applications open for BEVA Back in the Saddle

The British Equine Veterinary Association (BEVA) has opened applications for its 'Back in the Saddle' coaching programme.

The online scheme offers structured group coaching for members wanting to reflect on their career path and regain clarity. Members may be returning to work after leave, uncertain about next steps or reassessing direction.

Attendees will benefit from impartial guidance and practical tools to support their professional development. Members are encouraged to take a 'proactive, future-focused approach' to their careers.

The sessions, taking place on Wednesdays from 7.30pm-9pm, are open to BEVA members with more than five years' experience. The first session takes place on Wednesday, 3 June 2026.

Applications will close on Wednesday, 27 May 2026.